Edition:
United States

Masimo Corp (MASI.OQ)

MASI.OQ on NASDAQ Stock Exchange Global Select Market

101.27USD
15 Jun 2018
Change (% chg)

-- (--)
Prev Close
$101.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
195,308
52-wk High
$102.32
52-wk Low
$80.72

Chart for

About

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $5,244.28
Shares Outstanding(Mil.): 51.79
Dividend: --
Yield (%): --

Financials

  MASI.OQ Industry Sector
P/E (TTM): 26.92 40.41 34.18
EPS (TTM): 3.76 -- --
ROI: 28.11 14.36 13.17
ROE: 29.98 17.59 15.15

BRIEF-Masimo Q1 GAAP Earnings Per Share $0.82

* Q1 EARNINGS PER SHARE VIEW $0.69 -- THOMSON REUTERS I/B/E/S

May 02 2018

BRIEF-Masimo Announces CE Marking Of Rad-97 Pulse CO-Oximeter With Integrated NomoLine Capnography

* MASIMO ANNOUNCES CE MARKING OF RAD-97™ PULSE CO-OXIMETER® WITH INTEGRATED NOMOLINE™ CAPNOGRAPHY

Apr 10 2018

BRIEF-Masimo Corp Q4 GAAP Earnings Per Share $0.01

* QTRLY ‍TOTAL REVENUE, INCLUDING ROYALTY AND OTHER REVENUE, INCREASED 22.9% TO $225.2 MILLION​ Source text for Eikon: Further company coverage:

Feb 27 2018

BRIEF-Masimo Corp‍ Announced FDA Clearance Of Next Generation Sedline Brain Function Monitoring​

* MASIMO CORP - ‍ ANNOUNCED FDA CLEARANCE OF NEXT GENERATION SEDLINE BRAIN FUNCTION MONITORING​ Source text for Eikon: Further company coverage:

Jan 29 2018

BRIEF-Masimo Announces FDA Clearance For Home Use Of Rad-97

* MASIMO ANNOUNCES FDA CLEARANCE FOR HOME USE OF RAD-97™ Source text for Eikon: Further company coverage:

Jan 09 2018

Earnings vs. Estimates